TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Syncom Formulation (India) Ltd. ( (IN:SYNCOMF) ) has provided an update.
Syncom Formulations (India) Limited has announced its 37th Annual General Meeting (AGM) scheduled for September 29, 2025, to be held via video conferencing. Key agenda items include the adoption of financial statements for the year ending March 31, 2025, ratification of the remuneration for cost auditors, and the appointment of secretarial auditors for a five-year term. Additionally, the appointment of Shri Ankit Kedarmal Bankda as an Executive Promoter Director is to be confirmed. These decisions are expected to impact the company’s governance and operational strategies, ensuring compliance and strategic leadership continuity.
More about Syncom Formulation (India) Ltd.
Syncom Formulations (India) Limited operates in the pharmaceutical industry, focusing on the formulation and distribution of medicinal products. The company is involved in the production of a wide range of pharmaceutical formulations and has a market focus on providing quality healthcare solutions.
Average Trading Volume: 279,906
Technical Sentiment Signal: Buy
Current Market Cap: 15.92B INR
Find detailed analytics on SYNCOMF stock on TipRanks’ Stock Analysis page.